U-M's Kellogg Center soon to offer "bionic eye"
A retinal implant dubbed a "bionic eye" soon will be available to patients at the University of Michigan's Kellogg Eye Center.
Intended for patients with late stage retinitis pigmentosa, a disease that causes vision loss, the device is inserted in one eye, and the patient wears special glasses with a camera that captures the images and converts them into electrical impulses. The U.S. Food and Drug Administration recently approved the implants, and U-M's Kellogg center will be one of only 13 locations nationwide to offer the device.
Click here to watch a news video about the implant.
Visiting Professor lecture to focus on restoring vision loss
Robin Ali, Ph.D., a pioneer in the use of gene therapy and stem cells to restore damaged retinas, will speak in Ann Arbor on Nov. 5.
Click here for details.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
In the News
PBS series features institute director
"The Embrace of Aging," a documentary series airing Sundays at 2:30 p.m. on Detroit Public Televsion, features several interviews with Taubman Institute Director Eva Feldman, M.D., Ph.D.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.